Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Other Operating Expenses (2009 - 2026)

Updated

Abvc Biopharma's Other Operating Expenses was $863,647 in Q3 2026, down 25.9% from $1.17 million a year earlier but up 213.2% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Other Operating Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Abvc Biopharma's Other Operating Expenses was $3.38 million through Sep 30, 2026, up 4.1% year-over-year; for FY2025, it was $4.26 million, up 44.4% from FY2024.

  • Other Operating Expenses shows a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • In earlier years, Other Operating Expenses was $2.95 million in FY2024 (+211.8%), $946,812 in FY2023 (-90.0%), $9.44 million in FY2022 (+49.8%) and $6.31 million in FY2021 (+34.8%).
  • Quarterly Other Operating Expenses has moved between -$1.29 million (Q4 2023) and $5.05 million (Q1 2022) over five years.
  • Compared with a year earlier, Other Operating Expenses was higher in four of the last seven quarters, with growth averaging 311.6%.
  • The best year-over-year quarter for Other Operating Expenses over five years was Q1 2026 (growth of 956.8%); the worst was Q1 2025 (a decline of 96.3%).
  • Per Business Quant data, ABVC's Other Operating Expenses in the three quarters before Q3 2026 was $275,748 (Q2 2026), $820,474 (Q1 2026) and $1.42 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Abvc Biopharma 24.28 Mn 21.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 845,607.00
Jun 30, 2026 253,041.00
Mar 31, 2026 787,374.00
Dec 31, 2025 1.39 Mn
Sep 30, 2025 1.14 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 48,773.00
Dec 31, 2024 363,079.00
Sep 30, 2024 95,875.00
Jun 30, 2024 282,875.00
Mar 31, 2024 2.03 Mn
Dec 31, 2023 -1.22 Mn
Sep 30, 2023 817,740.00
Jun 30, 2023 225,740.00
Mar 31, 2023 366,489.00
Dec 31, 2022 1.89 Mn
Sep 30, 2022 225,740.00
Jun 30, 2022 225,740.00
Mar 31, 2022 44,239.00
Dec 31, 2021 4.38 Mn
API Access

Abvc Biopharma Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY